Crypto
Ripple Continues XRP Sales and Creates Price Pressure
Ripple’s XRP has struggled in 2024, dropping below $0.50. A Finbold analysis highlights Ripple’s continued XRP sales, with 150 million XRP ($78 million) sold in June alone. Despite market cap stability, these sales have pressured prices. Ripple’s management has been silent amid growing criticism, leaving XRP’s future uncertain despite a brief boost from a court victory against the SEC.
Ripple (XRP) has so far experienced a weak crypto year in 2024 in terms of price, with the price curve falling below the psychologically important mark of $0.50 over the weekend.
An analysis by Finbold that draws attention to Ripple’s handling of XRP reserves is attracting a lot of attention among investors. Based on blockchain data, the report shows that Ripple is continuing its XRP sales and has already cashed in at least 150 million XRP worth the equivalent of around $78 million in June.
Every month, Ripple automatically receives 1 billion XRP from an escrow account and this will continue for the next four years
In 2022 and 2023, however, Ripple left the allocated XRP untouched in most months. This year, the wind has changed and Ripple has sold between 200 and 260 million XRP every month. These coins were not previously in circulation and thus generate little inflation. But perhaps even more important is the direct price pressure that comes from XRP sales. Twelve Ripple sales days were counted in 2024 and on 7 of them the XRP price curve collapsed.
The issue that large-scale XRP sales could harm price development has been haunting Ripple for years. Co-founder Jed McCaleb was given 9 billion XRP when he left and sold it in tranches over almost a decade. It was not until the summer of 2022 that Jed McCaleb’s XRP account was emptied . Although rules were intended to prevent McCaleb from selling off a large amount of XRP in one go, theories about an influence on the price curve persisted.
Conclusion: XRP is stagnating – Ripple under criticism
Ripple’s XRP sales cannot be overestimated given the still powerful market capitalization of almost 28 billion US dollars, but the correlation with price pressure cannot be ignored from the charts. It is also striking that Ripple’s management has not commented further on the situation and strategies – although criticism is becoming increasingly louder on X and other networks.
Looking at the last twelve months, XRP has been treading water at prices of around 0.50 US dollars and a positive outlier after the court victory against the US Securities and Exchange Commission (SEC) has long been forgotten. How Ripple could usher in a trend reversal for XRP remains the crucial question if one wants to allow oneself to be optimistic.
__
(Featured image by Anna Tarazevich via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Crowdfunding2 weeks ago
Tifosy, UK Crowdfunding Platform Dedicated to Sport, Has Been Authorized by Consob
-
Fintech22 hours ago
Fintech Company Sonect Wants to Supply Europe with Cash
-
Africa2 weeks ago
Souss-Massa Launches ‘Back to Business’: Accelerating Investment with Bold Strategies
-
Biotech7 days ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA